Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
12 of 46 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Breast Neoplasms; Fatigue; Nausea; Vomiting; Piperazines; Phthalazines; BRCA1 Protein; BRCA2 Protein; Mutation; Quality of Life; Female
- PubMed ID
- 38301187
- PubMed Central ID
- PMC11095886
- Open access
- Yes, open
- Added to directory
- Source checked